Today

Agents

Chat

Arena

Discover

More

App

Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million - RNAC News | Rallies

Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million

RNAC•2026-08-06

Q2 operating income and expenses

Aug. 6 (Reuters) - Cartesian Therapeutics Inc Q2 operating income USD -29.155 million.

Q2 operating expenses USD 29.155 million

Related News

Helix Energy Q2 revenue misses estimates, withdraws annual guidance

HLX•2026-08-06

Zhengye Biotechnology regains Nasdaq compliance with $1 minimum bid price rule

ZYBT•2026-08-06

Fox beats fourth-quarter revenue estimates

FOXA•2026-08-06

H

Howmet Aerospace boosts 2026 forecasts as rising jet production drives demand for parts

HWM•2026-08-06

ALX Oncology Q2 Basic EPS USD -0.13

ALXO•2026-08-06